Bayer Consumer Health launches microbiome research call to find new academic partners
Campaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through…
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportCampaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through…
Building on a decade of research, a development program for next-generation probiotics and therapeutics to…
After decades of research, gut microbiome therapies are on the cusp of reaching the market.…
Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a…
The combination of advanced sequencing technologies and user-friendly data analysis solutions is bringing metagenomics into…
A new fermentation facility producing food ingredients and cultures, bacterial cultures, and probiotics has been…
For decades, soil has been treated as an everlasting food machine rather than as a…
Cell and gene therapies are taking off in a big way in Europe. As the…
Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in…
As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series…
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…